iTeos Therapeutics, Inc. (ITOS)
NASDAQ: ITOS · IEX Real-Time Price · USD
13.17
+0.82 (6.64%)
At close: Mar 27, 2024, 4:00 PM
13.42
+0.25 (1.90%)
After-hours: Mar 27, 2024, 7:23 PM EDT

iTeos Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018
Revenue
12.6267.63344.78000
Revenue Growth (YoY)
-95.29%-22.38%----
Gross Profit
12.6267.63344.78000
Selling, General & Admin
50.443.9540.5115.348.844.31
Research & Development
113.397.3659.3729.919.2117.19
Operating Expenses
163.7141.3199.8745.2428.0521.5
Operating Income
-151.1126.32244.9-45.24-28.05-21.5
Interest Expense / Income
000000.07
Other Expense / Income
-42.07-22.41-11.56-7.15-5.71-3.52
Pretax Income
-109.03148.74256.46-38.09-22.34-18.05
Income Tax
3.6152.0841.94-0.060.120.01
Net Income
-112.6496.65214.52-38.03-22.45-18.06
Preferred Dividends
0005.374.082.01
Net Income Common
-112.6496.65214.52-43.4-26.54-20.07
Net Income Growth
--54.95%----
Shares Outstanding (Basic)
3636351501
Shares Outstanding (Diluted)
3638381501
Shares Change
-5.30%-0.02%150.49%7336.29%-67.03%-
EPS (Basic)
-3.152.726.10-2.88-130.85-32.63
EPS (Diluted)
-3.152.565.68-2.88-130.85-32.63
EPS Growth
--54.93%----
Free Cash Flow
-106.72-112.13511.96-25.53-23.87-19.32
Free Cash Flow Per Share
-2.98-3.1514.55-1.69-117.69-31.42
Gross Margin
100.00%100.00%100.00%---
Operating Margin
-1199.69%47.20%71.03%---
Profit Margin
-894.34%36.11%62.22%---
Free Cash Flow Margin
-847.34%-41.90%148.49%---
Effective Tax Rate
-35.02%16.35%---
EBITDA
-108.13149.54257.07-37.56-21.72-17.48
EBITDA Margin
-858.53%55.88%74.56%---
Depreciation & Amortization
0.90.80.60.540.610.51
EBIT
-109.03148.74256.46-38.09-22.34-17.98
EBIT Margin
-865.66%55.58%74.39%---
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).